Another case of PML hits the MS drug Tysabri
PML is a rare demylinating disease that occurs in 6 per 10 million patients. This is the third case that is associated with Tysabri. Investors are not happy.
ADVERTISEMENT
More in Uncategorized
Past Week
Past 6 Months
Recent Posts
-
How new pancreatic cancer laser therapy works
-
How to prevent child sexual abuse [PODCAST]
-
Community hospital innovation: a survival story
-
California’s opioid policy hypocrisy
-
The physician’s change cycle: Why doctors stay stuck
-
A psychiatrist explains the new frontier of prescribed software treatments [PODCAST]
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
